Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Carcinoma, Non-Small-Cell Lung 2Neoplasms, Second Primary 1Leukemia, Myeloid, Chronic-Phase 1Gastro Intestinal Stromal Tumor 1Congenital Abnormalities 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Drug Therapy 2Tyrosine Kinase Inhibitors 1Trastuzumab 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Semen Analysis 1Registries 1Radiotherapy 1Patient Reported Outcome Measures 1Lenalidomide 1Interviews as Topic 1Data Collection 1Cisplatin 1Choledochostomy 1Bleomycin 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasms, Second Primary × Tyrosine Kinase Inhibitors × Clear all
NCT04151342 2025-12-03

CARMA-BROS

University Health Network, Toronto

Recruiting
5,500 enrolled

Congenital Abnormalities, Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡